Skip to main content
Erschienen in: Clinical Autonomic Research 6/2023

Open Access 04.08.2023 | Review Article

Day and night heart rate variability using 24-h ECG recordings: a systematic review with meta-analysis using a gender lens

verfasst von: Beatrice De Maria, Monica Parati, Laura Adelaide Dalla Vecchia, Maria Teresa La Rovere

Erschienen in: Clinical Autonomic Research | Ausgabe 6/2023

Abstract

Purpose

Increasing evidence demonstrates that gender-related factors, and not only biological sex, are relevant in the physiological and pathophysiological mechanisms of the cardiovascular system, including the cardiac autonomic regulation. Sex and gender may also affect daytime and night-time cardiac autonomic control. This meta-analysis aimed to provide a comparison between healthy women and men on heart rate variability using 24-h ECG recordings pointing out sex- and gender-related factors.

Methods

A systematic search was conducted to include studies focusing on both sex and gender differences related to heart rate variability indices in the time and frequency domains. Descriptive data were extracted by two independent reviewers. For each index, standardized mean differences with 95% confidence intervals were computed and a pooled estimate using a fixed- or random-effects model was applied.

Results

Twenty-seven studies were included in the meta-analysis. The results showed that only seven studies reported some information about gender-related factors. Concerning sex-related differences, women had a shorter mean RR interval and lower variability of the time domain indices than men.
Sex-related differences concerning frequency domain indices were more evident during night-time compared to daytime.

Conclusion

The characterization of gender-related factors in the study of heart rate variability using 24-h ECG recordings is still sporadic and underexplored. The meta-analysis results could not conclusively support a significant increase of high frequency power in women, although women showed a reduced total power and low frequency to high frequency ratio. There is a strong need for considering heart rate variability in relation to gender-related variables.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1007/​s10286-023-00969-3.
Beatrice De Maria and Monica Parati equally contributed to this work.

Introduction

It is well known that biological sex-related differences are relevant in a number of physiological and pathophysiological conditions, including cardiovascular ones [13]. However, psycho-socio-demographic factors causing different familial and societal engagement, usually referred to as gender-related factors, could also have an impact. While it is recognized that sex hormones influence the cardiovascular risk, it is conceivable that gender-related factors may also have an impact on the cardiovascular risk [4].
Nowadays, systematic sex-disaggregated data collection (i.e. data reported separately for male and female individuals) and their interpretation are still scarce, standardized methods for quantifying gender-related factors are lacking, and understanding of the relationships between sex and gender is largely incomplete [5], leading to a lack of specific and individualized treatments.
Over the past 30 years, the study of cardiac nervous control through the analysis of heart rate variability (HRV) has made it possible to investigate the etiopathogenesis of numerous cardiovascular and non-cardiovascular conditions and identify several prognostic indices; however, once again, sex-disaggregated data are scattered and the possible influence of gender is even more incomplete. HRV can be assessed over short periods of around 5 min under laboratory and controlled conditions, usually referred to as short-term HRV, and over longer recordings of about 24 h. In 2016, a meta-analysis [6], which mainly focused on short-term recordings and also included some analysis derived from 24-h recordings, showed that the autonomic control of the heart features some differences in female and male individuals, the former being characterized by relative dominance of vagal activity, despite greater mean heart rate (HR), and the latter by relative sympathetic dominance, despite lower HR. Moreover, sex-related differences are attenuated by ageing [7]. In addition, some studies evidenced the dependence of sex-related differences on the considered period, i.e. daytime or night-time [8]. A recent prospective comparative study of healthy subjects [9] has demonstrated that the autonomic cardiac control adjusts differently in response to the same physiological perturbations in women compared to men during daytime and night-time.
In order to consider both day- and night-time analyses, in addition to the fact that HRV derived from short or 24-h recordings is not directly comparable because of the different duration of the recordings [10], the present systematic review focuses only on 24-h recordings. The general aim is to provide an updated comparison between healthy women and men investigated by means of HRV analysis derived from 24-h electrocardiogram (ECG) recordings pointing out sex-related and gender-related influencing variables, day and night differences, and age-related influences.
In detail, the specific aims are (1) to compare the time and frequency domain HRV indices in male and female individuals; (2) to compare time and frequency domain HRV indices in men and women separately during daytime and night-time; (3) to assess whether differences between men and women are influenced by age; (4) to point out information about gender-related factors reported in the available studies that assess sex differences in HRV.

Methods

Protocol

The review was conducted in accordance with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analysis) statements. The review protocol was not recorded in an online register.

Database and search criteria

Three electronic databases (Pubmed, Embase, Scopus) were searched until 31 January 2023. Methodology search filters by study design, language or publication date were not applied to possibly minimize retrieval biases. The following keywords and related MeSH/Entree terms used in a previous systematic review on this topic [6] were appropriately combined using Boolean operators to create the search strategy for each database: sex, gender, gender identity, women, men, female, male, heart rate variability, heart period variability, HRV. Reference lists of the included studies were finally screened to identify any further related articles to be included.

Eligibility criteria

The inclusion criteria for this systematic review were:
1.
Articles assessing individuals with an age higher than 18 years.
 
2.
Subjects without pathologies and medication.
 
3.
ECG recordings ≥ 24 h.
 
4.
Outcome measures of HRV in time and frequency domain.
 
5.
Outcome measures separately reported from male and female populations.
 
6.
Sufficient quantitative data to perform meta-analysis technique between male and female groups (i.e. number of samples and descriptive statistics or individual data).
 
The exclusion criteria were:
1.
Data related to athletes.
 
2.
Reviews, meta-analyses, abstracts and comments.
 

Study selection and data extraction

All the retrieved records were merged and screened to remove duplicates. After duplicates were removed, the title and abstracts of all identified articles were independently evaluated by two reviewers (MP, BDM). Full texts of all potentially relevant articles were retrieved and their eligibility for this review was examined. The number of articles meeting the eligibility criteria, the number of excluded studies and the reasons for exclusion were recorded. Relevant data from eligible articles were extracted in a structured data extraction form by a reviewer (MP) and their accuracy was checked by a second reviewer (BDM). The relevant data mainly include anthropometric characteristics of participants, gender-related factors (i.e. any variable better describing the socio-economic status, behavioural and psychological conditions), experimental study design and outcome data. Any disagreement between the two reviewers during the retrieval process was resolved by discussion until a consensus was reached.

Data analysis

The HRV outcome indices included in this systematic review are listed and briefly explained in Table 1. In this review, only the internationally recognized indices for which the interpretation is univocal were considered. The standard deviation of the RR interval (SDNN) and the total power (TP) of the RR series were taken as overall indices of the amplitude of HRV oscillations [10]. The root mean square of successive differences between adjacent RR interval (RMSSD), the absolute and normalized power in the high-frequency band (HF, 0.15–0.40 Hz), labelled HF and HFnu, respectively, were taken as indices of the cardiac vagal modulation [10, 11]. The ratio of the RR power in the low-frequency band (LF, 0.04–0.15 Hz) to the HF power was taken as an index of the cardiac sympatho-vagal balance [10, 11]. For each HRV outcome, the measurements in each individual study were collected and combined whenever possible through meta-analysis techniques [12]. The HRV measures were treated as continuous data and therefore the mean, standard deviation and number of analysed participants in the two groups (male vs female) were recorded. Missing means and standard deviations in the individual studies were estimated by means of imputation from available data [12, 13]. If the measurements of an outcome were presented in the original studies as subgroups (e.g. data shown subdivided in age bins), their values were extracted and combined using the weighted means and the pooled standard deviations [12, 13].
Table 1
Outcome measures
Time domain analysis
 RR (ms)
Mean time interval between two consecutive R waves in milliseconds
 SDNN (ms)
Standard deviation of RR intervals in milliseconds
 RMSSD (ms)
Root mean square of successive differences between adjacent RR intervals in milliseconds
Frequency domain analysis
 TP (ms2)
Total power of RR series expressed in milliseconds squared
 HF (ms2)
Power of RR series in the high frequency band (0.15–0.40 Hz) in milliseconds squared
 HFnu (nu)
Power of RR series in the high frequency band (0.15–0.40 Hz) in normalized units
 LF/HF
Ratio between the low- (0.04–0.15 Hz) and high-frequency components of RR series
Regarding the first objective, the HRV indices derived from 24-h ECG recordings were considered in the analyses. If an article examined 24-h recordings and separately reported the measurement during daytime and night-time, their values were combined using weighted mean and pooled standard deviation [12].
As to the second study aim, the indices computed during daytime and night-time were separately examined.
The effect measures were estimated through the standardized mean difference (SMD) based on Hedges’ g, along with the 95% confidence interval (CI) [12, 14]. Heterogeneity among studies was evaluated using the I2 statistics and the χ2 test [12, 15]. We calculated the overall effects using a random-effect model in case of high heterogeneity (> 50%) or a fixed-effect model otherwise [16]. A positive effect size conventionally means that the male population showed a higher value in the outcome measure compared to the female population.
As it is known that HRV decreases with ageing [17, 18], mixed-effect meta-regression analyses were used to analyse the influence of the mean subject age on the sex-related effect. In order to have sufficient power, meta-regression was only performed for HRV indices reported in at least ten studies [12].
The meta-analyses were performed using Review Manager 5.4 software [19]. The meta-regression analyses were computed using R 4.0 software. The null hypothesis of no statistical difference was rejected if the p value was less than 0.05.

Results

Search results and study characteristics

A total of 9760 articles were originally found in the literature. After duplicate and eligibility screening, 27 studies from 29 articles were included in this systematic review. The flow diagram of the study selection process is shown in Fig. 1.
The main characteristics of the included studies are shown in Table 2. Overall, they were published between 1991 and 2022. A total of 16 (59%) studies were conducted in Europe, 9 (33%) in America, 1 (4%) in Asia and 1 (4%) in Africa.
Table 2
Main characteristics of the included studies
Authors
Country
M, n
F, n
Age M, years
Age F, years
BMI M, kg/m2
BMI F, kg/m2
Sample type
Psychosocial variables
Length of recording
DAY vs NIGHT
System
SR, Hz
Time domain indices
Frequency domain indices
Beckers et al. [34]
Belgium
141
135
NR (18–71)
NR (18–71)
25 ± 3
23 ± 4
Healthy subjects
No
24 h
Yes
ELA Medical Holter
200
RR, SDNN, RMSSD
TP, HF, HFnu, LF/HF (FFT—iterated analysis, windows of 128 s, 50% overlap)
Bonnemeier et al. [46, 47]
Germany
85
81
43 ± 3 (20–70)
42 ± 3 (20–70)
23 ± 1
22 ± 1
Healthy healthcare professionals and their family members; healthy former patients with atypical chest pain
No
24 h
No
Tracker II, Reynolds, Hertford, UK
NR
RR, SDNN, RMSSD
NR
Bigger et al. [48]
USA
202
72
57 ± 8 (40–69)
NR
NR
Healthy employees and persons who responded to newspaper advertisement
No
24 h
No
Marquette 8000
NR
RR
NR
De Maria et al. [9, 49]
Italy
50
50
35 ± 5 (28–48)
37 ± 7 (25–49)
25 ± 3
23 ± 3
Healthy healthcare professionals
Yes
24 h
Yes
eMotion Faros 360°, Mega Electronics, Finland
500
RR
TP, HF (AR—iterated analysis, windows of 250 RRs, overlap of 200 RRs)
Extramiana et al. [50]
France
30
30
34 ± 9 (20–50)
NR
NR
Healthy subjects
No
24 h
Yes
Del Mar 459 Recorder, Del Mar Avionics, Irvine, California
NR
RR, SDNN, RMSSD
NR
Genovesi et al. [51]
Italy
20
20
29 ± 4 (NR)
27 ± 4 (NR)
23 ± 2
21 ± 2
Healthy sedentary subjects
No
24 h
Yes
ELA Medical, Le Plessis Robinson, France
200
RR, SDNN
NR
Hulsegge et al. [20]
Denmark
292
251
46 ± 10 (18–68)
27 ± 5
Healthy blue-collar workers
Yes
96 h
No
Actiheart monitor
NR
RR, SDNN RMSSD
TP, HF, LF/HF (NR—iterated analysis, windows of 300 s, no overlap)
Jensen-Urstad et al. [52]
Sweden
49
53
NR (20–69 years)
25 ± 3
23 ± 3
Healthy healthcare professionals, students and blood donors
No
24 h
No
Reynolds Sherpa, Reynolds Medical, Hertford, England
NR
RR, SDNN, RMSSD
TP, HF, LF/HF (AR—iterated analysis, windows of 300 s, no data about overlap)
Jensen-Urstad et al. [21]
Sweden
63
70
35 ± 0 (NR)
25 ± 2
23 ± 4
Healthy subjects
Yes
24 h
Yes
Reynolds Sherpa, Reynolds Medical, Hertford, England
NR
RR
TP, HF, LF/HF (AR—iterated analysis, windows of 300 s, no data about overlap)
Kashiwagi et al. [53]
Japan
15
17
49 ± 14 (NR)
50 ± 11 (NR)
NR
NR
Healthy subjects
No
48 h
Yes
NR
NR
NR
HFnu (NR—iterated analysis, windows of 512 RRs every 30 min)
Krauss et al. [54]
Germany
63
76
41 ± NR (20–77)
42 ± NR (20–77)
NR
NR
Healthy subjects
No
24 h
No
Tracker II, Delmar Reynolds, Hertford, UK
NR
RR, SDNN, RMSSD
NR
Lampert et al. [22]
USA
87
70
30 ± 1 (18–50)
29 ± 1 (18–50)
28 ± 1
28 ± 1
Healthy community dwelling subjects
Yes
24 h
No
GE Seer and Seer Lite
125
SDNN
NR
Li et al. [55]
USA
35
60
55 ± 8 (NR)
58 ± 8 (NR)
27 ± 3
27 ± 6
Healthy community dwelling subjects
No
24 h
No
Mortara Instrument, Inc., WI, USA
1000
RR, SDNN, RMSSD
LF/HF (FFT—iterated analysis, windows of 300 s, no overlap)
Lerma et al. [56]
Mexico
20
30
29 ± NR (21–36)
27 ± NR (21–36)
23 ± NR (23–32)
23 ± NR (22–27)
Healthy subjects
No
24 h
No
Burdik-Spacelabs, 92,513, Dreefield
200
RR, SDNN, RMSSD
TP, HF, HFnu, LF/HF (FFT—NR)
Marin-Farrona et al. [23]
Spain
47
66
39 ± 6
39 ± 6
25 ± 2
24 ± 2
Healthy office workers
Yes
48 h
No
Firstbeat Bodyguard device, Firstbeat Technologies Ltd., Jyväskylä, Finland
NR
RMSSD
NR
Molnar et al. [57]
USA
11
10
57 ± 12 (36–76)
57 ± 15 (36–76)
NR
NR
Healthy subjects
No
24 h
No
Marquette 8000 T Laser Holter
NR
RR
NR
Pitzalis et al. [58]
Italy
44
45
26 ± 6 (NR)
27 ± 4 (NR)
24 ± 2
21 ± 3
Normotensive subjects with and without family history of hypertension
No
24 h
No
Del Mar Avionics Model 445A, Irvine, California, USA
NR
RR, SDNN RMSSD
NR
Ramaekers et al. [30]
Belgium
141
135
41 ± 14 (18–71)
43 ± 15 (18–71)
25 ± 3
23 ± 4
Healthy subjects
No
24 h
No
NR
200
RR, SDNN, RMSSD
TP, HF, HFnu, LF/HF (FFT—iterated analysis, windows of 256 s, overlap of 50%)
Strauss et al. [24]
South Africa
284
396
25 ± 3 (NR)
25 ± 3 (NR)
25 ± 5
26 ± 6
Black and white healthy subjects
Yes
24 h
No
Card(X)plore, Meditech, Budapest, Hungary
NR
RR, SDNN
HFnu, LF/HF (NR—NR)
Sammito et al. [59]
Germany
319
376
40 ± 10 (NR)
40 ± 11 (NR)
27 ± 4
25 ± 4
Healthy office employees, healthcare professionals, students and military
No
24 h
No
Schiller MT-101, Firma Schiller AG, Baar, Switzerland
1000
SDNN, RMSSD
HFnu, LF/HF (FFT—iterated analysis, windows of 256 s, overlap of 50%)
Sztajzel et al. [60]
Switzerland
14
18
29 ± 3 (NR)
NR
NR
Healthy medical students, residents and technicians
No
24 h + 24 h
Yes
NR
NR
RR, SDNN, RMSSD
TP, HF, HFnu, LF/HF (FFT—NR)
Sosnowski et al. [61]
Poland
173
37
50 ± 6 (NR)
NR
NR
Healthy subjects
No
24 h
No
MEdilog Excel 2 System, Oxford Instruments, Abingdon, UK
NR
RR, SDNN
NR
Stein et al. [62]
USA
30
30
50 ± 4 (NR)
NR
NR
Healthy subjects
No
24 h
Yes
Marquette series 8500, Milwaukee, Wisconsin
NR
RR, SDNN, RMSSD
LF/HF (FFT—iterated analysis. Windows of 300 s, no overlap)
Stein et al. [25]
USA
18
18
37 ± 9 (23–59)
NR
NR
Healthy subjects
Yes
24 h
Yes
ACS Holter, Ontario, CA
NR
RR, SDNN, RMSSD
LF/HF (FFT—iterated analysis. Windows of 300 s, no overlap)
Sevre et al. [63]
Norway and Netherlands
19
15
54 ± 3 (NR)
51 ± 1 (NR)
26 ± 1
27 ± 1
Healthy subjects
No
24 h
No
Marquette series 8500
NR
RR
NR
Umetani et al. [64]
USA
65
81
NR (30–69)
NR
NR
Healthy subjects
No
24 h
No
Cardionostics Dura-Lite recorder (Cardionostics), Epicardia 4000 53A-01
NR
RR, SDNN, RMSSD
NR
Van Hoogenhuyze et al. [65]
USA
19
14
33 ± 7 (NR)
34 ± 8 (NR)
NR
NR
Healthy subjects
No
24 h
No
Marquette 8500
NR
RR, SDNN
NR
Data are reported as mean ± standard deviation. As to age, when declared, the age range is reported in brackets
M male, F female, BMI body mass index, DAY daytime, NIGHT night-time, SR sampling rate, RR RR interval, SDNN standard deviation of the RR intervals, RMMSD square root of the mean squared differences of successive RR intervals, TP total power, HF power of the RR series in the high frequency band (0.04–0.15 Hz), HFnu normalized HF, LF/HF LF to HF ratio, FFT fast Fourier transform, AR autoregressive model, NR not reported
The sample size of the studies varied between 21 and 695 enrolled subjects. The total number of individuals considering all included studies was 4592. The mean male-to-female ratio was 1.2 with a standard deviation of 0.8; the maximum ratio was 4.7 while the minimum was 0.6.
Just 15 studies (56%) reported the mean age separately for the male and female populations. The lower mean age of enrolled subjects was 25 ± 3 years, and the highest was 57 ± 8 years.
All included subjects were healthy. Some studies included healthcare professionals and hospital staff (15%, n = 4) or office employees (15%, n = 4). Only 7 studies (26%) reported some additional psychosocial variables of the studied population. These variables included occupation and lifestyle habits [9, 20], risk factor assessment [21], stress evaluation [9, 22, 23], work ability [23], socio-economic status [24], pain tolerance [25] and psychological measures related to functional health status, depression, anger and anxiety [25].
Most studies (85%, n = 23) were conducted using a 24-h ECG recording, and only 4 (15%) used multiday recordings. The used recording system was almost always described, while the sampling rate was reported only in 8 studies (30%). The results of the time domain analysis were reported in all but one study. The results of the frequency domain analysis were reported in 15 studies (56%).
As to the frequency domain analysis, details about the performed analysis are reported in the last column of Table 2. Eight studies estimated the power spectrum by means of fast Fourier transform, three applied an autoregressive model and three studies did not report this information. The majority of the studies performed an iterated analysis over short time windows ranging from 128 s to 8 min, while three studies did not report any information. The overlap ranged from no overlap to 80% overlap.
Data reported separately for daytime and night-time were available only in 9 (33%) studies.

Effect sizes during 24-h recordings

As shown in Fig. 2, meta-analyses of the time domain indices revealed that the male population had a significantly longer RR interval (SMD [95% CI] 0.57 [0.38, 0.75], p < 0.001, 2711 subjects, 21 studies), a higher SDNN (SMD [95% CI] 0.56 [0.48,0.64], p < 0.001, 2538 subjects, 18 studies) and a higher RMSSD (SMD [95% CI] 0.18 [0.08, 0.28], p < 0.001, 1531 subjects, 14 studies) compared to the female population. All these indices showed low heterogeneity levels (I2 < 49%), except for the RR interval (I2 = 77%).
Regarding the frequency domain analyses (Fig. 3), the male population showed significantly higher TP (SMD [95% CI] 0.50 [0.34, 0.65], p < 0.001, 692 subjects, 6 studies) and LF/HF (SMD [95% CI] 0.59 [0.49, 0.69], p < 0.001, 1641 subjects, 10 studies) compared to the female population. A positive trend in favour of the male population was noticed for the HF power, but statistical significance was not reached (SMD [95% CI] 0.14 [− 0.01, 0.29], p = 0.07, 692 subjects, 6 studies). Instead, the female population was characterized by a significantly higher HFnu compared to men (SMD [95% CI] − 0.52 [− 0.63, − 0.40], p < 0.001, 1238 subjects, 6 studies). The analysis related to the frequency domain indices demonstrated low heterogeneity levels (I2 < 10%). Meta-analysis findings during 24-h recordings are summarized in Table 3.
Table 3
Time and frequency domain indices—24 h
Domain
Indices
Studies
Participants
Statistical methods
I2 (%)
Effect size (M vs F)
p value
Time
RR
21
2711
Std. mean difference (IV, random, 95% CI)
77
0.57 [0.38, 0.75]
< 0.001
SDNN
18
2538
Std. mean difference (IV, fixed, 95% CI)
48
0.56 [0.48, 0.64]
< 0.001
RMSSD
14
1531
Std. mean difference (IV, fixed, 95% CI)
0
0.18 [0.08, 0.28]
< 0.001
Frequency
TP
6
692
Std. mean difference (IV, fixed, 95% CI)
9
0.50 [0.34, 0.65]
< 0.001
HF
6
692
Std. mean difference (IV, fixed, 95% CI)
0
0.14 [− 0.01, 0.29]
0.07
HFnu
6
1238
Std. mean difference (IV, fixed, 95% CI)
0
− 0.52 [− 0.63, − 0.40]
< 0.001
LF/HF
10
1641
Std. mean difference (IV, fixed, 95% CI)
0
0.59 [0.49, 0.69]
< 0.001
Positive effect size indicates higher values for men, while negative effect size higher values for women

Effect sizes during daytime recordings

During daytime (Fig. 4), significant sex differences were noticed for the RR interval (SMD [95% CI] 0.52 [0.15, 0.89], p = 0.006, 604 subjects, 7 studies) and the SDNN (SMD [95% CI] 0.35 [0.03, 0.67], p = 0.03, 504 subjects, 6 studies). No differences were found for RMSSD between female and male populations (SMD [95% CI] 0.06 [− 0.27, 0.39], p = 0.73, 464 subjects, 5 studies). High heterogeneity levels were observed for all the time domain indices (I2 ≥ 56%).
With regard to the frequency domain outcomes (Fig. 5), the male population showed a significantly higher LF/HF (SMD [95% CI] 0.57 [0.36, 0.78], p < 0.001, 372 subjects, 3 studies, I2 = 0%) compared to the female one, where HFnu was significantly higher in the female population (SMD [95% CI] − 0.41 [− 0.64, − 0.18], p < 0.001, 308 subjects, 2 studies, I2 = 0%). No significant sex difference was observed for TP (SMD [95% CI] 0.34 [− 0.09, 0.77], p = 0.12, 376 subjects, 2 studies) and HF (SMD [95% CI] 0.16 [− 0.05, 0.36], p = 0.13, 376 subjects, 2 studies) together with relatively high heterogeneity (I2 = 45–72%).

Effect sizes during night-time recordings

During night-time (Fig. 6), significant sex differences and high heterogeneity were shown for the RR interval (SMD [95% CI] 0.49 [0.21, 0.77], p < 0.001, 1147 subjects, 8 studies, I2 = 73%) and SDNN (SMD [95% CI] 0.48 [0.26, 0.71], p < 0.001, 1047 subjects, 7 studies, I2 = 51%). A positive non-significant trend in favour of the male population and a low heterogeneity level was seen for RMSSD (SMD [95% CI] 0.11 [− 0.01, 0.24], p = 0.07, 1007 subjects, 6 studies, I2 = 0%). Examination of the frequency domain indices (Fig. 7) revealed that the male population was characterized by a significantly higher TP (SMD [95% CI] 0.33 [0.05, 0.61], p = 0.02, 919 subjects, 3 studies) and LF/HF (SMD [95% CI] 0.52 [0.39, 0.65], p < 0.001, 915 subjects, 4 studies). In addition, a significant sex difference was noticed for HFnu, with women being characterized by higher values (SMD [95% CI] − 0.61 [− 0.84, − 0.38], p < 0.001, 308 subjects, 2 studies). A positive, non-significant trend in favour of the male population was seen for HF (SMD [95% CI] 0.11 [− 0.02, 0.24], p = 0.09, 919 subjects, 3 studies). High heterogeneity levels among the included studies were shown by the meta-analyses of TP (I2 = 73%), whereas all the other frequency domain indices featured low heterogeneity (I2 ≤ 2%). Meta-analysis findings during daytime and night-time are respectively summarized in Tables 4 and 5.
Table 4
Time and frequency domain indices—daytime
Domain
Indices
Studies
Participants
Statistical methods
I2 (%)
Effect size (M vs. F)
p value
Time
RR
7
604
Std. mean difference (IV, random, 95% CI)
75
0.52 [0.15, 0.89]
0.006
SDNN
6
504
Std. mean difference (IV, random, 95% CI)
57
0.35 [0.03, 0.67]
0.03
RMSSD
5
464
Std. mean difference (IV, random, 95% CI)
56
0.06 [− 0.27, 0.39]
0.73
Frequency
TP
2
376
Std. mean difference (IV, random, 95% CI)
72
0.34 [− 0.09, 0.77]
0.12
HF
2
376
Std. mean difference (IV, fixed, 95% CI)
45
0.16 [− 0.05, 0.36]
0.13
HFnu
2
308
Std. mean difference (IV, fixed, 95% CI)
0
− 0.41 [− 0.64, − 0.18]
< 0.001
LF/HF
3
372
Std. mean difference (IV, fixed, 95% CI)
0
0.57 [0.36, 0.78]
< 0.001
Positive effect size indicates higher values for men, while negative effect size higher values for women
Table 5
Time and frequency domain indices—night-time
Domain
Indices
Studies
Participants
Statistical methods
I2 (%)
Effect size (M vs. F)
p value
Time
RR
8
1147
Std. mean difference (IV, random, 95% CI)
73
0.49 [0.21, 0.77]
< 0.001
SDNN
7
1047
Std. mean difference (IV, random, 95% CI)
51
0.48 [0.26, 0.71]
< 0.001
RMSSD
6
1007
Std. mean difference (IV, fixed, 95% CI)
0
0.11 [− 0.01, 0.24]
0.07
Frequency
TP
3
919
Std. mean difference (IV, random, 95% CI)
73
0.33 [0.05, 0.61]
0.02
HF
3
919
Std. mean difference (IV, fixed, 95% CI)
0
0.11 [− 0.02, 0.24]
0.09
HFnu
2
308
Std. mean difference (IV, fixed, 95% CI)
0
− 0.61 [−0.84, − 0.38]
< 0.001
LF/HF
4
915
Std. mean difference (IV, fixed, 95% CI)
2
0.52 [0.38, 0.65]
< 0.001
Positive effect size indicates higher values for men, while negative effect size higher values for women

Meta-regression on age covariate

Meta-regression was performed for RR, SDNN, RMSSD and LF/HF during 24-h recordings (see Appendix 1 in the supplementary material). These analyses revealed only a significant effect on SDNN. In detail, the previously positive effect for SDNN (i.e. higher in the male population than female population during 24-h recordings) was significantly diminished with increasing age (β = − 0.014, [95% CI − 0.024; − 0.003], SE 0.005, z-score − 2.56, p = 0.011, k = 18). The meta-regression results on SDNN are displayed in Fig. 8.

Discussion

To the best of our knowledge, this was the first meta-analysis trying to separately analyse data over daytime and night-time periods in relation to sex and gender differences in HRV. Despite the limited number of studies reporting day and night information, we observed that night-time values are most consistent than daytime values in describing sex differences. As to gender, we observed that very few studies included spotted psychosocial variables and that no studies included exhaustive information about gender.
In line with a previous meta-analysis including both HRV derived from short and 24-h ECG recordings [6], the present systematic review exploring only HRV calculated over 24-h ECG recordings in healthy populations confirmed that women show a higher mean heart rate and a lower variability of the time domain indices compared to men. Our data did not definitively support an increased parasympathetic modulation in women assessed by absolute HF power, although HFnu was consistently higher in women.
Sex-related differences in HR and HRV are a long-lasting topic in the literature. In a 1983 publication on 24-h ECG recordings from 260 healthy subjects aged 40–79, Bjerregaard found that mean HR was lower on average in male than in matched female counterparts [26]. Not only sex, but also age, smoking and leisure-time activity were found to be relevant variables in determining HR. The first studies that included the analysis of HRV date back to the early 1990s. The most accredited opinion is that of a different autonomic profile between the sexes, where women are characterized by greater vagal activity (as assessed by absolute and normalized HF powers) despite a higher resting HR and reduced variability of time domain indices [6]. However, the higher vagal modulation in women could not be the only interpretation of this phenomenon. Indeed, the lower HRV in women could also be linked to an intrinsic effect of the acetylcholine concentration on the diastolic depolarization of the pacemaker cells that generates lower HR oscillations in the presence of shorter RRs, while higher HR oscillations are produced in the presence of longer RRs [27, 28].
The results of the present review related to the most HRV indices are in line with Koenig and Thayer [6]. The result that seems to disagree with Koenig and Thayer [6] is the one related to the absolute HF power. Indeed, Koenig and Thayer [6] found a statistically significant increase in this index in women compared to men. However, the effect size was low (− 0.05 [− 0.07, − 0.03]), as it was in the present review (0.14 [− 0.01, 0.29]), suggesting that the difference between men and women is very small and possibly due to conflicting results among the included studies. It also has to be considered that in our review we focused only on HRV indices derived from 24-h ECG recordings in uncontrolled conditions, whereas Koenig and Thayer [6] included most studies concerning short ECG recordings under mixed controlled conditions, including controlled breathing and supine position. This could also explain the contrasting results with our meta-analysis, as the power in the HF band is sensitive to the respiratory rate [29]. Similar to the results of the present meta-analysis, other authors found no significant differences in absolute HF power between men and women, while a higher LF/HF ratio has been attributed to a predominant sympathetic modulation in men [30]. It remains to be established whether a small effect size of the absolute HF power is due to a similar cardiac vagal modulation in women and men or due to methodologically heterogeneous studies. Indeed, the power in the HF band could be sensitive to both the length of the period considered for analysis and the method of analysis [10]. The high heterogeneity of the methodological approaches could be responsible for the conflicting results about the comparison between men and women with regard to the power in the HF band. This bias prevents definitive conclusions from being drawn, and suggests the need for further rigorous research on this topic.
Based on classical physiology, HR in healthy individuals depends on the influence of both divisions of the autonomic nervous system on the intrinsic activity of the sinus node. Thus, HR is usually regarded as a gross marker of the autonomic interaction at the sinus node level. Accordingly, a fast HR has been associated with all-cause mortality and sudden cardiac death in the general population and in patients with heart disease [31, 32], although the strength of this association seems to be somewhat weaker in women [33].
The results of the meta-regression analysis showed that the differences between men and women are more evident in young adults than in the elderly when time domain indices, specifically SDNN, are considered. This observation suggests that the sex-related differences are attenuated by the ageing process, in agreement with previous studies [6] and possibly explained by the different hormonal settings of women in the younger age compared to menopause [18]. This is in keeping with a previous study [18] demonstrating that HRV complexity decreased more markedly in women after menopause compared to age-matched men, flattening the differences between the two sexes, probably due to the physiological reduction of oestrogens during menopause [30, 34, 35]. Intrinsic limitations of the meta-regression analysis to be disclosed are the linearity of the method and the use of the subjects’ mean age in the included studies, only a rough index of the real age, as a covariate. These limitations, together with the inability to perform the analysis according to women’s life span phase, since the majority of the included studies did not report any information, could explain non-significant findings in the other HRV indices.

Sex hormones and HRV

Sex hormones, in particular oestrogens, may account for some of the observed phenomena in HRV. A recent review examined the link between HRV, reproductive life stages, and menopausal hormone therapy [36]. All but one study included in the review showed a decrease of the vagal dominance on the heart from the follicular to the luteal phase with higher LF power and LF/HF ratio towards the luteal phase and HF power decreasing from the follicular to the luteal phase. While a decrease in all the HRV parameters points to a reduced parasympathetic modulation, the administration of replacement therapy reverses the trend.
In addition, ovarian hormones can modulate central autonomic networks through oestrogen receptors localized in three major autonomic regions including the rostral ventrolateral medulla, the nucleus of the solitary tract, and the paraventricular nucleus of the hypothalamus [37].
Even during pregnancy, women show modifications of their autonomic profile, indicating that either hormones or hemodynamic changes or their interrelationship interfere with it [38].
All the above-mentioned evidence suggests that sex hormones have a role in determining a different autonomic control of the heart in women. Thus, a clear bias raises when interpreting HRV data in meta-analyses, since information about the hormonal stage, sex-related factors, or gender-related variables influencing the autonomic profile are not generally available.
Along this line, a recent review provided a tenable explanation for the presence of sex differences in cardiac function on a neural structural level [39]. Interestingly, this study showed a greater cortical thickness in the majority of brain regions associated with vagal outflow in women. Moreover, this study also showed that cortical thickness in brain regions associated with vagal outflow is significantly associated with HRV, but not HR [39]. Further support for the existence of core differences in the chronotropic control of the heart across sexes comes from a subsequent study from the same group showing that the association between HRV and HR is different in women and men [40]. In detail, at any given level of HRV, the heart period was found to be faster in women compared to men [40].
Today we pay the price for having long neglected the analysis of sex and gender. The lack of sex-disaggregated data may have led to a generalized misinterpretation of the data [41].
Moving to a clinical scenario, this would explain why the constant “hyperdynamic” condition of the female heart [42] does not portend a worse incidence and prognosis of cardiovascular diseases.
Despite the paucity of studies separately assessing the differences between male and female subjects during daytime and night-time, interesting results derived from the present review. Differences between men and women, in particular concerning HRV indices in the frequency domain, were more evident during night-time compared to daytime. The main reasons should be attributed to the uniformity and standardization of the night-time period in terms of activity that characterizes all the studied subjects [43]. During the night-time period, all the subjects are supposed to sleep, the influence of the physical activity is minimized and the influence of different respiratory patterns is also attenuated. However, the observed results should also be a consequence of sex-related differences in sleep regulation. Previous studies suggested opposite results comparing women and men during wakefulness and sleep, men being characterized by greater vagal modulation during daytime compared to women, but less vagal modulation during rapid eye movement sleep [8]. Therefore, the aforementioned observations suggest that future studies should try to separately analyse daytime and night-time periods, possibly selecting the periods for analysis based on the activity that subjects are performing during the Holter ECG recording. This could be achieved using a manual or electronic diary where activities are precisely documented in order to select periods for analysis in accordance. For instance, during night-time attention should be paid to the time in bed and the number and length of the awakenings. Of course, this approach is not free from limitations, as a comprehensive sleep analysis should consider the recording of a complete polysomnography to describe sleep stages and respiratory activity [44]. However, the strategy of selecting periods for analysis based on reported activities is an attempt to standardize the analysis and limit bias with a simpler experimental setup. The same approach could be used also during the daytime to study the effect of precise activities, for instance, working activities, periods of relaxation or physical exercise.

Gender and HRV

The results of the present review underlined that the effect of gender on HRV is very poorly investigated, in the presence of ever-increasing importance of this topic [45]. Indeed, less than 30% of the studies included in this review reported some information about gender-related factors. However, none of the studies reported exhaustive information about gender, a concept that should consider more than one factor (such as ethnicity, socio-economic factors, gender identity and geographical location). In addition, sex-disaggregated data are sometimes omitted; it is noteworthy that only 56% of the studies separately reported the age of men and women.
As to the real implementation of gender-related aspects in HRV, our results strongly encouraged the inclusion of gender-related variables when designing new experimental protocols.

Limitations

This review with meta-analysis has some limitations that deserve mention. Although the broad search string and the literature search were performed in three pertinent electronic databases by two independent reviewers, it is not possible to exclude that some articles have been missed. Also, given the paucity of published data for daytime and night-time analyses, the meta-analyses were based on the results from a limited number of heterogeneous studies. In addition, the paucity of information about methodological details, such as sampling rate or appropriate description of the analytical methods for ECG analysis, limits possible speculation about the comparability of the included studies in terms of methodological adequacy.

Conclusion

This updated review aimed to assess sex differences in HRV assessed over 24-h ECG recordings, with a particular focus on day and night differences and gender variables. We confirmed the sex-related differences in both the time and frequency domain of HRV, with women being more tachycardic than men and with a lower variability of the time domain indices.
In the night-time period, the aforementioned differences between women and men seem to be more pronounced, possibly due to a standardization of the state of the subjects during the night. Of interest, very few studies reported scattered data about gender factors and almost no studies reported exhaustive information about them.
Therefore, we point out the need for future research to propose a methodological approach to study gender in HRV, promoting the broad inclusion of gender-related aspects and standardized and/or precisely described procedures to collect and analyse the ECG recordings in relation to subjects’ activities.

Declarations

Conflict of interest

The authors declare no conflict of interest.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Unsere Produktempfehlungen

Neuer Inhalt

Print-Titel

e.Med Interdisziplinär

Kombi-Abonnement

Jetzt e.Med zum Sonderpreis bestellen!

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt bestellen und 100 € sparen!

Anhänge

Supplementary Information

Below is the link to the electronic supplementary material.
Literatur
10.
Zurück zum Zitat Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93(5):1043–1065 Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93(5):1043–1065
12.
Zurück zum Zitat Higgins JPT, Thomas J, Chandler M, Li T, Page JM, Welch A (2019) Cochrane handbook for systematic reviews of interventions. Wiley, ChichesterCrossRef Higgins JPT, Thomas J, Chandler M, Li T, Page JM, Welch A (2019) Cochrane handbook for systematic reviews of interventions. Wiley, ChichesterCrossRef
19.
Zurück zum Zitat Nordic Cochrane Center. Review Manager (RevMan), version 5.4. Copenhagen: the Nordic Cochrane Center, the Cochrane collaboration, 2021 Nordic Cochrane Center. Review Manager (RevMan), version 5.4. Copenhagen: the Nordic Cochrane Center, the Cochrane collaboration, 2021
21.
Zurück zum Zitat Jensen-Urstad M, Jensen-Urstad K, Ericson M, Johansson J (1998) Heart rate variability is related to leucocyte count in men and to blood lipoproteins in women in a healthy population of 35-year-old subjects. J Intern Med 243(1):33–40CrossRefPubMed Jensen-Urstad M, Jensen-Urstad K, Ericson M, Johansson J (1998) Heart rate variability is related to leucocyte count in men and to blood lipoproteins in women in a healthy population of 35-year-old subjects. J Intern Med 243(1):33–40CrossRefPubMed
32.
Zurück zum Zitat Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R, BEAUTIFUL investigators (2008) Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 372(9641):817–821. https://doi.org/10.1016/S0140-6736(08)61171-XCrossRefPubMed Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R, BEAUTIFUL investigators (2008) Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 372(9641):817–821. https://​doi.​org/​10.​1016/​S0140-6736(08)61171-XCrossRefPubMed
39.
Zurück zum Zitat Koenig J, Abler B, Agartz I, Akerstedt T, Andreassen OA, Anthony M, Bar K, Bertsch K, Brown RC, Brunner R, Carnevali L, Critchley HD, Cullen KR, de Geus EJC, de la Cruz F, Dziobek I, Ferger MD, Fischer H, Flor H, Gaebler M, Gianaros PJ, Giummarra MJ, Greening SG, Guendelman S, Heathers JAJ, Herpertz SC, Hu MX, Jentschke S, Kaess M, Kaufmann T, Klimes-Dougan B, Koelsch S, Krauch M, Kumral D, Lamers F, Lee T, Lekander M, Lin F, Lotze M, Makovac E, Mancini M, Mancke F, Mansson KNT, Manuck SB, Mather M, Meeten F, Min J, Mueller B, Muench V, Nees F, Nga L, Nilsonne G, Ordonez Acuna D, Osnes B, Ottaviani C, Penninx BWJH, Ponzio A, Poudel GR, Reinelt J, Ren P, Sakaki M, Schumann A, Sorensen L, Specht K, Straub J, Tamm S, Thai M, Thayer JF, Ubani B, van der Mee DJ, van Velzen LS, Ventura-Bort C, Villringer A, Watson DR, Wei L, Wendt J, Schreiner MW, Westlye LT, Weymar M, Winkelmann T, Wu G, Yoo HJ, Quintana DS (2021) Cortical thickness and resting-state cardiac function across the lifespan: a cross-sectional pooled mega-analysis. Psychophysiology 58(7):e13688. https://doi.org/10.1111/psyp.13688CrossRefPubMed Koenig J, Abler B, Agartz I, Akerstedt T, Andreassen OA, Anthony M, Bar K, Bertsch K, Brown RC, Brunner R, Carnevali L, Critchley HD, Cullen KR, de Geus EJC, de la Cruz F, Dziobek I, Ferger MD, Fischer H, Flor H, Gaebler M, Gianaros PJ, Giummarra MJ, Greening SG, Guendelman S, Heathers JAJ, Herpertz SC, Hu MX, Jentschke S, Kaess M, Kaufmann T, Klimes-Dougan B, Koelsch S, Krauch M, Kumral D, Lamers F, Lee T, Lekander M, Lin F, Lotze M, Makovac E, Mancini M, Mancke F, Mansson KNT, Manuck SB, Mather M, Meeten F, Min J, Mueller B, Muench V, Nees F, Nga L, Nilsonne G, Ordonez Acuna D, Osnes B, Ottaviani C, Penninx BWJH, Ponzio A, Poudel GR, Reinelt J, Ren P, Sakaki M, Schumann A, Sorensen L, Specht K, Straub J, Tamm S, Thai M, Thayer JF, Ubani B, van der Mee DJ, van Velzen LS, Ventura-Bort C, Villringer A, Watson DR, Wei L, Wendt J, Schreiner MW, Westlye LT, Weymar M, Winkelmann T, Wu G, Yoo HJ, Quintana DS (2021) Cortical thickness and resting-state cardiac function across the lifespan: a cross-sectional pooled mega-analysis. Psychophysiology 58(7):e13688. https://​doi.​org/​10.​1111/​psyp.​13688CrossRefPubMed
56.
Zurück zum Zitat Lerma C, Vallejo M, Urias K, Hermosillo AG, Cardenas M (2006) Differences in cardiac autonomic modulation between women and men. Arch Cardiol Mex 76(3):277–282PubMed Lerma C, Vallejo M, Urias K, Hermosillo AG, Cardenas M (2006) Differences in cardiac autonomic modulation between women and men. Arch Cardiol Mex 76(3):277–282PubMed
65.
Zurück zum Zitat Van Hoogenhuyze D, Weinstein N, Martin GJ, Weiss JS, Schaad JW, Sahyouni XN, Fintel D, Remme WJ, Singer DH (1991) Reproducibility and relation to mean heart rate of heart rate variability in normal subjects and in patients with congestive heart failure secondary to coronary artery disease. Am J Cardiol 68(17):1668–1676. https://doi.org/10.1016/0002-9149(91)90327-hCrossRefPubMed Van Hoogenhuyze D, Weinstein N, Martin GJ, Weiss JS, Schaad JW, Sahyouni XN, Fintel D, Remme WJ, Singer DH (1991) Reproducibility and relation to mean heart rate of heart rate variability in normal subjects and in patients with congestive heart failure secondary to coronary artery disease. Am J Cardiol 68(17):1668–1676. https://​doi.​org/​10.​1016/​0002-9149(91)90327-hCrossRefPubMed
Metadaten
Titel
Day and night heart rate variability using 24-h ECG recordings: a systematic review with meta-analysis using a gender lens
verfasst von
Beatrice De Maria
Monica Parati
Laura Adelaide Dalla Vecchia
Maria Teresa La Rovere
Publikationsdatum
04.08.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Autonomic Research / Ausgabe 6/2023
Print ISSN: 0959-9851
Elektronische ISSN: 1619-1560
DOI
https://doi.org/10.1007/s10286-023-00969-3

Weitere Artikel der Ausgabe 6/2023

Clinical Autonomic Research 6/2023 Zur Ausgabe

Neu in den Fachgebieten Neurologie und Psychiatrie

Blutdrucksenkung schon im Rettungswagen bei akutem Schlaganfall?

31.05.2024 Apoplex Nachrichten

Der optimale Ansatz für die Blutdruckkontrolle bei Patientinnen und Patienten mit akutem Schlaganfall ist noch nicht gefunden. Ob sich eine frühzeitige Therapie der Hypertonie noch während des Transports in die Klinik lohnt, hat jetzt eine Studie aus China untersucht.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.